Explore more publications!

The Middle East Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Middle East Health Journal.

Press releases published on November 21, 2025

Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study
Injured Workers Call for End to Discriminatory Age-Based Cut-Offs at WSIB REPORT RELEASE & QUEEN’S PARK PRESS CONFERENCE -- Tuesday November 25th 9:30am
XRPH AI Expands Global Footprint as New Vitals Dashboard Strengthens Africa’s First HIPAA-Grade AI Health Platform
Sharecare wins 22 Digital Health Awards in Fall 2025 competition
MAIA Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
Global Surgical Microscopes Market to Surpass USD 2.59 Billion by 2030 | MarketsandMarkets™
American Kidney Fund Hosts Third Patient Access Initiative Summit to Address Barriers to Kidney Care and Propose Innovative Solutions
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Emerging as Leader with New Independent JV Valuation
OKYO Pharma Announces Chairman and Founder Acquires Shares
New Data at the Asia Pacific Heart Rhythm Society (APHRS) 2025 Highlight the Performance of iRhythm’s Zio Long-Term Continuous Monitoring in an Asian Population
第18回アジア太平洋不整脈学会学術大会(APHRS2025)で発表された新たなデータにより アジア人集団におけるiRhythm社のZio長期連続モニタリングの性能が明らかに
Sangamo Therapeutics Announces FDA Acceptance of BLA Rolling Submission Request for ST-920 in Fabry Disease
60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine
Adlai Nortye to Participate in Upcoming Investor Conferences
XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V.
Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025
Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma
Anaptys Announces $100 Million Stock Repurchase Plan
Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions